These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector. Soifer H; Higo C; Kazazian HH; Moran JV; Mitani K; Kasahara N Hum Gene Ther; 2001 Jul; 12(11):1417-28. PubMed ID: 11485633 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus facilitated infection of human cells with ecotropic retrovirus. Scott-Taylor TH; Gallardo HF; Gänsbacher B; Sadelain M Gene Ther; 1998 May; 5(5):621-9. PubMed ID: 9797866 [TBL] [Abstract][Full Text] [Related]
5. Transient foamy virus vector production by adenovirus vectors. Russell RA; Vassaux G; Martin-Duque P; McClure MO Gene Ther; 2004 Feb; 11(3):310-6. PubMed ID: 14737091 [TBL] [Abstract][Full Text] [Related]
6. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells. Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389 [TBL] [Abstract][Full Text] [Related]
7. Retrotransposon-adenovirus hybrid vectors: efficient delivery and stable integration of transgenes via a two-stage mechanism. Soifer HS; Kasahara N Curr Gene Ther; 2004 Dec; 4(4):373-84. PubMed ID: 15578988 [TBL] [Abstract][Full Text] [Related]
8. Retroviral vectors for high-level transgene expression in T lymphocytes. Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967 [TBL] [Abstract][Full Text] [Related]
9. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors. Logg CR; Tai CK; Logg A; Anderson WF; Kasahara N Hum Gene Ther; 2001 May; 12(8):921-32. PubMed ID: 11387057 [TBL] [Abstract][Full Text] [Related]
10. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401 [TBL] [Abstract][Full Text] [Related]
11. A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette. Wang H; Lieber A J Virol; 2006 Dec; 80(23):11699-709. PubMed ID: 16987973 [TBL] [Abstract][Full Text] [Related]
12. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector. Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924 [TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus. Oehmig A; Fraefel C; Breakefield XO; Ackermann M Curr Gene Ther; 2004 Dec; 4(4):385-408. PubMed ID: 15578989 [TBL] [Abstract][Full Text] [Related]
14. Genomic integration and gene expression by a modified adenoviral vector. Zheng C; Baum BJ; Iadarola MJ; O'Connell BC Nat Biotechnol; 2000 Feb; 18(2):176-80. PubMed ID: 10657124 [TBL] [Abstract][Full Text] [Related]
15. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system. Tashiro F; Niwa H; Miyazaki J Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924 [TBL] [Abstract][Full Text] [Related]
16. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932 [TBL] [Abstract][Full Text] [Related]
17. Replicative retroviral vectors for cancer gene therapy. Solly SK; Trajcevski S; Frisén C; Holzer GW; Nelson E; Clerc B; Abordo-Adesida E; Castro M; Lowenstein P; Klatzmann D Cancer Gene Ther; 2003 Jan; 10(1):30-9. PubMed ID: 12489026 [TBL] [Abstract][Full Text] [Related]
18. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
19. A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression. Wang H; Shayakhmetov DM; Leege T; Harkey M; Li Q; Papayannopoulou T; Stamatoyannopolous G; Lieber A J Virol; 2005 Sep; 79(17):10999-1013. PubMed ID: 16103151 [TBL] [Abstract][Full Text] [Related]
20. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Olmsted-Davis EA; Gugala Z; Gannon FH; Yotnda P; McAlhany RE; Lindsey RW; Davis AR Hum Gene Ther; 2002 Jul; 13(11):1337-47. PubMed ID: 12162816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]